-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HB49UyC+mcgfUISMCanOBJ9BNHa7lBumyYIKWEac7V0U8yHaduEiRLbIQVHnVODz
 765zoq1BtcnxNrb8q45zMg==

<SEC-DOCUMENT>0000950157-09-000571.txt : 20090902
<SEC-HEADER>0000950157-09-000571.hdr.sgml : 20090902
<ACCEPTANCE-DATETIME>20090902163152
ACCESSION NUMBER:		0000950157-09-000571
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20090902
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20090902
DATE AS OF CHANGE:		20090902

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRISTOL MYERS SQUIBB CO
		CENTRAL INDEX KEY:			0000014272
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				220790350
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01136
		FILM NUMBER:		091051245

	BUSINESS ADDRESS:	
		STREET 1:		345 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10154
		BUSINESS PHONE:		2125464000

	MAIL ADDRESS:	
		STREET 1:		345 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10154

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRISTOL MYERS CO
		DATE OF NAME CHANGE:	19891012
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
    <title>form8-k.htm</title>
<!-- Licensed to: Cravath, Swaine & Moore LLP-->
<!-- Document Created using EDGARizer 5.1.2.0 -->
<!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>
<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%"></div></div>
<div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br>&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">UNITED STATES</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">SECURITIES AND EXCHANGE COMMISSION</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington, D.C. 20549</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman">FORM 8-K</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CURRENT REPORT</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date of Report (Date of earliest event reported): <a name="QuickMark">September 1, 2009 </a></font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 24pt; FONT-FAMILY: Times New Roman">BRISTOL-MYERS SQUIBB COMPANY</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Exact Name of Registrant as Specified in its Charter)</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="30%" style="TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Delaware</font></div></td>
<td valign="top" width="40%" style="TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1-1136</font></div></td>
<td valign="top" width="30%" style="TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22-079-0350</font></div></td></tr><tr>
<td valign="top" width="30%" style="TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(State or Other Jurisdiction of Incorporation)</font></div></td>
<td valign="top" width="40%" style="TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Commission File Number)</font></div></td>
<td valign="top" width="30%" style="TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(IRS Employer Identification Number)</font></div></td></tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div></td>
<td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="40%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">345 Park Avenue</font>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">New York, NY, 10154</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Address of Principal Executive Office)</font></div></font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="40%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Registrant&#8217;s telephone number, including area code:&#160;&#160;(212) 546-4000</font></font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr></table></div></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="DISPLAY: inline; FONT-STYLE: italic">see </font>General Instruction A.2. below):</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings">o</font>Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings">o</font>Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>
<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%"></div></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br>&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div></div>
<div id="PN" style="PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: blue" noshade size="2"></div></div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div></div></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 8.01.&#160;&#160;Other Events.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On September 1, 2009, Bristol-Myers Squibb Company (the &#8220;Company&#8221;) announced the completion of the acquisition of all outstanding shares of common stock, par value $0.01, of Medarex, Inc., a New Jersey Corporation (&#8220;Medarex&#8221;), together with the associated rights to purchase Series A Junior Participating Preferred Stock
of Medarex issued pursuant to the Rights Agreement, dated as of May 23, 2001, as amended, between Medarex and Continental Stock Transfer &amp; Trust Company (the &#8220;Shares&#8221;), that were not already owned by the Company and its subsidiaries.&#160;&#160;The acquisition of the Shares was structured as a two-step transaction, with a cash tender offer by Puma Acquisition Corporation, a New Jersey corporation and a wholly owned subsidiary of the Company (the &#8220;Purchaser&#8221;), for the Shares at a price
of $16.00 per Share, net to the seller in cash, without interest and less any required withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated July 28, 2009, and in the related Letter of Transmittal, each as amended and supplemented, filed by the Company and the Purchaser with the Securities and Exchange Commission on July 28, 2009, followed by the merger of the Purchaser with and into Medarex.&#160;&#160;The press release is attached as Exhibit 99.1 to this Current
Report and is incorporated herein by reference.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 9.01.&#160;&#160;Financial Statements and Exhibits</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;Exhibits</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Press release dated September 1, 2009</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left">
<br>&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div></div>
<div id="PN" style="PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: blue" noshade size="2"></div></div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div></div></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">BRISTOL-MYERS SQUIBB COMPANY</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Registrant</font></div></font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div></td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By: </font></div></td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/&#160;Jeremy Levin</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:&#160; Dr. Jeremy Levin</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:&#160;&#160;&#160; Senior Vice President, Strategic <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Transactions</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr></table></div>
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">September 2, 2009</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div></div>
<div id="PN" style="PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: blue" noshade size="2"></div></div>
<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div></div></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br>&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT INDEX</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit No</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 124px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">99.1.</font></div></td>
<td width="858">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Press release dated September 1, 2009</font></div></td></tr></table></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<br></div></div></body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
<head>
    <title>ex99-1.htm</title>
<!-- Licensed to: Cravath, Swaine & Moore LLP-->
<!-- Document Created using EDGARizer 5.1.2.0 -->
<!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div>&#160;</div>
<div><img src="bms-newsbanner.jpg" alt=""></div>
<div><img src="bms-logo.jpg" alt=""></div>
<div>&#160;</div>
<div>&#160;</div>
<div>&#160;</div>
<div align="left">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="72%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="6%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="94%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bristol-Myers Squibb Completes Acquisition of Medarex, Inc.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160; &#160;</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 2; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(NEW YORK, September 1, 2009)<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>-- Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has completed its previously announced $2.4 billion acquisition of Medarex, Inc. (NASDAQ: MEDX) (&#8220;Medarex&#8221;).&#160;&#160;As a result of the transaction, Medarex
has become a wholly-owned subsidiary of Bristol-Myers Squibb.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 2; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Bristol-Myers Squibb initiated on July 28, 2009 a cash tender offer to purchase all outstanding shares of common stock of Medarex for $16.00 per share.&#160;&#160;The tender offer period expired at midnight (New York City time) on August 26, 2009, and the subsequent offering
period relating to the tender offer expired at midnight (New York City time) on August 31, 2009, at which time shareholders of Medarex had tendered in aggregate approximately 120,417,467 shares of Medarex common stock which, together with the 2,879,223 shares of Medarex common stock owned by Bristol-Myers Squibb since January 2005, represented approximately 90.7% of the Medarex shares outstanding.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 2; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Today, Bristol-Myers Squibb acquired all of the remaining outstanding shares of Medarex common stock by means of a &#8220;short form merger&#8221; in which all such shares were converted into the right to receive $16.00 per share, in cash and without interest, less any required withholding taxes.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 2; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">This press release is neither an offer to purchase nor a solicitation of an offer to share shares of Medarex.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">About Bristol-Myers Squibb</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life.&#160; For more information, visit: <font style="DISPLAY: inline; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">www.bms.com</font>.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Contacts</font></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Media:</font> Brian Henry, 609-252-3337, brian.henry@bms.com</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Investors:</font> John Elicker, 609-252-4611, john.elicker@bms.com</font></div>&#160;</font></td></tr><tr>
<td width="6%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="94%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td></tr></table></div>
<div>&#160;</div></body>
</html>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>bms-newsbanner.jpg
<TEXT>
begin 644 bms-newsbanner.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``@%!@<&!0@'!@<)"`@)#!0-#`L+#!@1$@X4'1D>'AP9
M'!L@)"XG("(K(AL<*#8H*R\Q,S0S'R8X/#@R/"XR,S$!"`D)#`H,%PT-%S$A
M'"$Q,3$Q,3$Q,3$Q,3$Q,3$Q,3$Q,3$Q,3$Q,3$Q,3$Q,3$Q,3$Q,3$Q,3$Q
M,3$Q,3$Q,?_$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`"L"V`,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`&RRR"=QN;[Q[GUKZ*R1X<G(A\UMA(9A@>M/;1D7>XOFON&&
M8D^_O2#FMH`E8J,.P_$T[\H^9L7?(#Q(V1Q]XTK]`3:=QWF/GEV_`TK:#<FM
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MT+Q-D`6-_C'7YJR56DNJ-'1JM;&;??VC8S&&Z>X@EQ]QV(/\ZUBXR5TC-\T7
M9E;[9=;3_I$PX_YZ&GR1[`I/8=]LN5))N9N/^FA]*7+%VT"[MH+]MNMH'VB;
MC`^^:?+':P*3ON)]NN<D_:)NW'F'_&ERKL)2E84WET#Q<S8'^VU396V'%RZD
MMM+?W<RPVLEQ-(Y(549B3^`IR2CN./,[)&B-%\3`_P#'GJ0'^ZU1[2CW1?LZ
MO9F4]W=HY#W$ZE2007/'MUJN6*6A#YKNS-"UTWQ!=0":VM[^6-NC(&(//:I<
MZ<7JT:1A4:NB0Z+XE0;C9ZB`.IP]3[2E=:H/9U4MC-\V_P!LI$MQB$9D^9OD
MYQS^/%;6B97DF1?;;KDBYFX_Z:&CEC;82E+N/>XOA%YWGW`B9MJMO.,^F:22
MVL.\K;C/M]SVN9O;YS2Y%V'S2Z,=+/?1;0\MRA9=RY<\CUJHJ(KS6Y;LK'7;
MZ/S+.*_GB/&^/>0/RJ)3IQT;1<54DKHEGTSQ';PO)+:ZC&B\EF#@`4HSI/2Z
M&XU(WNF9O]H71;`N9\>OF&M>5;F7-*VX&_N\\74V!T_>'_&ER12U%SR[@+ZZ
M`&V[G]?]81_6AQ2Z%<\KWN/6_O,#_2I\Y_YZ-_C4I+L/F=]Q/[0N\<7=QZ?Z
MUO\`&JY5V%S2NK,%U&]S_P`?EQ@'IYK?XTN2/8KFEW+UI%KMY&)+-;^=%X+1
MEV'TR*SE*$7[UD"522N@NUUW3]IO/M\"L<`R%E!/IS33@]K`XR6KN5[6ZU2Y
MD$5M/=S2-P%1V)-6U&*U2"+ET+XT_P`49_X]]4].CU/M*7D/DJKN5;P:Y8JK
MWIO[=2V`9&=0?SIQ<'HK"?M(J[N5GO\`48GVRW5TA*@C,K#@]#UJ^56T1+G.
MVC!-2OW<*MY=%B<`"5N3Z=:+12V0<TUU!]2U"-F5KR[1DR"IF;(.>AYI65]D
M-SEM<='J&I.6\N[NFP"<+*QX_.BT5;0.:36C!=0U&1A'%>73.3@`2MS^M-**
MU:0*<V]S0-MXER<1:H/^_E9<U/R_`T2J>96N[C6+*15NYKZ`L>`[NI([FJ3@
MUI8S;J+<K+JU_P![ZY'`_P"6S5?*ET7W"YY+J*=7U$-C[==#YN/WK=/SHY(V
MT0E*2ZCO[6U$+_Q_7(_[;-_C4\J[!SON(=6U`'`OKDXS_P`M6_QJE&/5!S/N
M*-8U'@?;KD?]MF]O>E[./82G+N.BU;5)"JQWMTSGHHE;/MWI<D5NBE*7<NJ/
M$H`4?VICUR]1>GOH:.%7S*;ZKJT;,C7]VCC@@RL,'WY^E6HQTT,VY)[EBUN/
M$%RGF03:B\?'*NY_E2:IQ70M>TZ7)E;Q(I&7U(<?WGJ'[+I8&JOF53JFLJ[(
M;V]4I]Y?-8%?4D5?LX=D+FG?<9_;>J`X_M*[QSSYS?XT.G#>Q/M9KJ.&LZL5
MWKJ%X$4XSYK8!STZT>SA'2VH^>?<5==U/J=2NQN/3SFX_6ATH=$A>TDNH#6]
M74`MJ-[@]#YS8_G5>S@NB'[2=]V36^IZY<9-O>7\F!SMD<X_6I<*<=TBE4F]
MFR5KWQ%C/GZDN.OSO4M4EI9`I5+=2JVO:L,_\3&[!'8S-_C5*G#^4GVD]K@-
M>U7/_(2NQ_VV;_&G[*'9"]K-=1?^$@U8<#4;L^G[YNE-4H=D'M)_S#AK^JYX
MU&[_`._K>E1[.%OA#VDU+<&U_5CC&I7:D],RG_&J5.FMT@]I4[B'Q!JP`*ZE
M=9ST,K<T>Q@MT@]K/N36^L:Y.?W-[?28/(5V.*4J=-+5)#52HUHQ9=6U^%"T
MMW?1CGEG8"CDI-V20<U1:MLC_M_62P5-1NB>.!(>?:CV5/L+VE2^C98_M'Q$
M,9N;_'0\M4\E+LB^:IW8DFJZ_$FZ6\OD4'DEB*:A2>R1+G53W9`?$&L@`G4;
MK!&?]8?TIJE33^$7M)VW`>(=7QSJ5T.?^>AINE3O\*#VD_YA?^$AUA#AM0NA
M@=Y#[T.E#HD-5*G=B_\`"0:N&Q_:-T?3$AH5.F_LH7M:G</^$AUCI_:-T,=?
MWAI^RIK[*&JL[V;+":KXA(!%W>X8$CDU')2[(KVM7HQDNMZ]$-SWMX@[;F(I
MJG3VLA>TJ+=C1XBU@,!_:=P`.OSTO90M\(G7J+J-7Q)K)/\`R$[C_OJJ=&G_
M`"A[:I;<<OB36`!G4[@^IW=.E'LH?RH2KU.YD7/_`!\2D_=$C`?F:OR1$^I$
M#M''!_2ADVW0AQG`'\7&/:JZBV0BC"XS@@'\^U&FX[ZC^"PXQVI;(-3J_`6C
M6]U]HU+4TW65BA.&Z,W7\>*Y,34<;0CNSKP]-.\Y;(K+XQUF`F*RNC%;ACY<
M>Q3L7)P,D=A5/#T]Y+4CV\U\+T-[Q;-)'X1L_P"UY//U.Z(=2W'EKUX`]N/Q
MK&@DZCY5:*.BJ[4US;LA@C7PYX%^U-A;^^D5X2,94`Y!_`9/XTYOVM:RV1*_
M<T;]68__``F_B'_G_P#I^[7_``K5X:DNAE]9J+J-\*V5QXE\31G4)'G53YLS
ML<\#)Q].@IU9*E2O'0*2=:IJ0^.M0CU+Q)<R0*OEQGRU*\;MO?\`/-.A'V<$
MF37GSSNMC<\'P0Z)X:OO$5U&ID8&.W##GTX^I./PKGKMU*BIHZ**5.FYLXN"
M%[BX6*/+23-A<=R37;)VNV<J3D['9^,HX='TJQ\.V,8$TH5[DJ.7;/`/KSG\
MJY*#<VZLOD=-9*$53B+KNSP9::?%IN$U9EWSS?>.",$8],X_*E#_`&AMR^'H
M.HU122W,B3QUXAD1E^W!5;J1&H(%;?5J2Z&?UF;1SCR/,[2R.S.>6+$DD^I-
M=&VASZWN(1TSP,X_7_Z])OL";M=B'C.,9'44`M1P.T87DBE;6XA5'1<<D@'/
MY53TU#5#H49I%2-2S,V`,9-2TMRM3MM;$?@JUT^'2PJ:J4WSRGYOEQR,?7^5
M<=.]=R<OA.RHU124=RUX-\0Z]K^K?9KB[5;6-2\S)&`<>@/N:FO3I4X7BM2Z
M4YSE9F/;Z?;Z_P".7@LX\67FEF&<Y0?>/XG^=:N3I4==S",54J^[L6O$'B^]
MTW7KNWT.18K57`8;=P+`8)'IT_2E2H0E33J;E5*THR:@8VH^+M<U.U^SW5WB
M)OO+&NW</0FM%1IPU2U,G7J25F;MK;PZ!\/;FYN$5KG5/DC5AT7M_4UC*7M*
MR2V1LDJ=)M[LX[2K"74-0ALH`?,F<*"/X<GK^5=4Y<L7)G+"'.TD=-\2)K:V
MFL]$L$58K%,OM'5S_7O^-<V'3:<Y;LZ<0TK0CT&?#W1[>[NKG4=11396";F#
M?=+?YR?RIUYN*48[L*$$VY/9$_ARRB\5^([W4]17%C!ERN<#'\*_3`J:DO8Q
M48[CA!59N4MBD/'.IV1DM]*>*&S1V\F-H\[5))`S5_5X/XEJ1]8FOAV,S6_%
M&K:U&B7]R3$I^X@V@GW'>M8484]8HRG6E/1F/V`YX[]ZUN[W(V=A>4/O_D4G
MH2(",XQ@=N>U,;'Y"X(_'UJ4B>FHB@,@YZ\53;15E>YU'@/0(-7O9IK_`#]A
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MK9WGB'4$5X;)3Y6X?Q@9R/?_`!K'$2;:IQZE4(I)U&CD+B5[B\EE*@//(9"H
M]22?ZUU)621R2U=SL_$%K#X:\)6FG11@:A?J/M#G[VSJ1_(5R4VZE1RZ+8[9
M)4J:5M6)<VD7@_0=.OHT!UFX82`OR$7'(Q]#^9JD_;S<?LH+*DE+JRL_Q&UX
MQD*UL">A$9X]^M-82F1]:F<M>WEQ?7+7%Y*\LK\LS-G_`/5]*ZHQ25H['-*4
MI.[(6.6X(_+_`#ZTTM"%YB$DDDGOTII6!;BMUZG`'6DMD.W+T`GT_#%"'N*`
M<=.F"!35D1ML=O<6L/A#1-.OT16UFX(=?,&0BX.1CZ'\ZXE)UYRC]E'?R*C%
M-?$7/#?C#7];UF*P4VZ*QS(ZQ'*KW/6LZE"E3AS%4ZU2<N4Q]>L(=4\<-8:9
MN.^0+(Y.<O\`Q-713DX4N>1E47-5M$V/$?B:3PUK#V&AB)88XU60.N1O`[<]
M<8S6%*DJD.:9I4J.E+E@8U_X^UR\MG@\V*`-P6B7#8^OXUO'#4HNZ1D\14EH
M:/A6U@T[PKJFN:D@D,T;11J_\>>#^9XK.K)RJ1A'H71CR0<Y=3BH87EG2*-2
M7=MJJ.YKL>FO0Y%KH=CXWM[70M#T_1(47[02)KAQU+8(Y_$G\JY,/>I-SZ;(
MZZZ4(J"W,OP-HBZSK2I<J?LL*^9,/;L/Q-:8BHZ<;K?H94*?//7H:,=G%XK\
M8F"W'DZ=;?*NP``1KUQ]2:AS="EKN;*/M:EN@Z3Q>_A^[N;#0X8/L<<I"EUR
MQ['GOSFDJ'M4I5-R76=)N,-BCK/C;6-5MC;-(EO&<[A""I;ZFM(8>G3=TB)8
MB<U9G-G=Z<@GI70DCGZB9^;CCGGVIVTL+8.IP.WX4;#22U8JDY#=!G_"ERZ6
M%:S%<_*.2.!UI6UL%]'<U?"FC/KFLQ6FYEB/S2,O\*CK_GWJ*U14Z;9K1ASS
MY3H&\5?\(U?7>GZ);PM:QR$!Y!EB0,'GOR#7/]7]LE*>YT.M[-N,%H:\FJS:
MWX-O;[6E2&V`*Q)&,%W[=??%8*FJ=51I[FBDZE-N>QB>!M*@^QZAJVH@BWMH
MRJ'I\V.2/<?UKHQ%1WC".[,,/!).;V1+'\1M62-5-M;/@8+$')XJ?J=-O<:Q
M<S)U;7=4\3WD5M(^U&<*D$?"YSU]ZVA2A0BV93JSJNQH^/H+/38M,TNW53/:
MPYD<>Y_J<FLL/*4Y2F]FS7$)048KH4_`FB1ZOK!>Z3-K;+YDH['K@9K7$5'3
MAIN]B:%)2EKLC.\174=_K=W=P*JPN^%`Z;0`!_*KI)P@HLRJ2YIMHZ+3K&WT
M3PE)K-W$'OK@E+4$9VYX!`_,USRDZE7V:VZG1"$:=/G>[(=,TBVLO#,FO7V6
ME9Q]FC;E6.>"?49ISJ.554X_,F%-1I^TEOT+)^(VHHN%LK4`=!R*E8.F^K*>
M+DMD<UKFN7NM71DO),J!\L:\*GT'T-=5.E&FK1.:I4E-^\9^[)^OS?RK0S2T
ML*22=QY(Z\8H?<+B+@'!.<''M32MJ%WT%O#MO)ACI(W'XU%M%8II7(>1P.*=
MA=!",?,3CUXZ&BW1`]'9"@].,'(YI=1.RV%52[*J\L<<#Z4=-1I,Z?5]4GTS
M0AX<CLY+5LAKAY.&<DY.,=NV?:L(04I^TO?L=,ZG+#V=K=S$T:&:;481%:O=
M['#-$HSN`/2M)M*.]C."N]%<Z#5;R3Q3XJ!%O*8(``8EP65%^][9SFL(15&E
MN:RDZU31:'3:_HUIXB-O)/K-M;1PIMCBC(8`?F/:N:G4=*Z46SHJ4XU=Y'&>
M*=!L='B0VFK17DC'YHU^\!Z\9KKI595'K&QRU:4:>J9/INK3^&-#=$L95NM2
M3*SN,*$Q@;?4\Y_*E.G&K.[>B*4G2CHMSF(HI)9%CA#/)(<*`,DGI70WIKT.
M:W1'0>*M>DN;6UT>*V-M#8HJNAZF0#!_K6-*DHMS;O?\CHJ5&[12M8@\&226
MFM17S64EU#;`LY4?<_VO3BBO%2CRWLR:&C3:V+ND:K!J/C4:EJ+*`TA:%78!
M0?X03V`ZU,X.-+EB:0DI5>9G1Z[X2AUK4IKVZUVW5Y!@(`"$'H.:YZ==TXJ*
MB;U**G+F<CCO%/ATZ))$8KA;N"4X$B#`W>E==&I[1/2QR5J7L]4]#!+YYZ#K
MBM]C))"EC@X]QC%))*PK]Q2W&..IZ46N"6HI;[V.O3FA*VB$)GD'/Y4%7-SP
MH197C:M<6DMS;V1W$1KD;S]W)[#G]*PJKF7(G9LUIM1?,UL5=;U:;6=5FOIP
M$,G"H.0HXP/\^M5""A%103FYOF-K1=8?0_"]^/LDL,UZ0L5R1A6'<#Z`DUE.
MFIS5GMT-83<(-6U9L?#ZW:SL)V.RUNKM#Y<TWR@)TROJ<_R%98C5]TC2@E%.
MVER";P!;`-+)K\``!+,1^?>A8F25N03PT>LCE;'3C)JYM(B;R*-MSO`I;<@Y
M)7\*ZI2LN9Z'*H^]9:EKQAXB?7;F%(H#;VMJA2*(GD>_UXQ2HTO9)N^II6J>
MTV6Q)X.U'^Q9[G5IK1[A8HRD;`<+(2`,GZ9HKPYTH)V"E+V=Y6,6]NIKZ]EN
MIF)EG;>V/4^G\JTC'EC8R<N9ZG1SZP]AX)32%LY;6>Y<L[R#`E3U'Z"L.1.K
MSWND;NHX4N6VK-SPM;PZAX-ETZRO(+9YR?M,KM\V3V"^F!CFL:MXU>9J_8WI
M<KIV3*%U\.TB@=DUFW=P.$Q]X]A5+$N_PD/#+=,XB9'MY7AF`1T8JRGU!Z5V
MI76AQ25FTT1DYX!`'2BUM0VW0`D8R<]S2Z!HA0.!].*-@]1#]WCIZ?@::\P\
MAX4DX`Y![?7_`.M1?H)JVQU-QK7]C^&'T&&UFAN[@![F60;>O8?AQ7,J?--5
M+Z=#JY^2#A8YW3XR]Y"JQ/.!)D(@^9AGH*Z)>[>YSQZ:'3>*M1/B77[6SM89
MH[>V78(MF63`RW'MC'X5S4H.C%M]3HJS]I))'5:]X=?Q'8V4=K>P6EE;IB*/
M.XGC&3CBN6%7V4G=79TSI\Z2O9'%^*?"0T"!9FU2VG)/^J!P^/8=Z[*5;VFB
MC8Y:M'V:NF2^&-7B\,:=-?2VLTEW=(4MV*X0*.IR>O/IZ4JE/VKY;Z(<)>Q3
MDUJSF6>2:61G):21BY)[D_\`UZZ'9(YVSI=>UT)X>LO#]K;R6YB"O<[A@ECS
MC]0?RKGA1]]U-S>=:T%!(RO##(NM6DTUK-<QQR!FCB7<W'_U\5I/X&D[&=/2
M:;5S9N-7MM>\=1W5VVVS24+&IXRJ]!STR?YUDJ;I4N5;FSDJE2[V.H\3^$;W
MQ%J`NY+^V@4*%2+);:O^-<U*O&DK)'15H.H[W.*\3^&)]!"M]ICN8R<,T>?E
M/OZ5V4ZRJ]+''4H>SZW.?+'M@$5LM#*P<`XZ<8^E5J)I7%&2><C_`/52MV%H
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MUC%M9D/"M:W..NK=[6>2*5<.IQCWKMB[K0Y)1Y&TR(L-H(SSR13$`)W9X/M0
M[[`'=OS)S1;J)V#';IC^=%M`#!!Z\TKV0M#K-!UBW\-Z%<[$D.IWD9\KY<!%
M[')]_P"5<U2FZLE?9'7"<:2>FK.8QEANRQ8\\9S72GV.7=V1U7B?5H+O2M*T
M?3$D6*)5:164JV[H!COW/Y5S4H.,I39UU*BM&$3HY-#NM1\(VNE:0\44(PTT
MLI(\P]3@#)Z^OI7*ZD857.9T>S<J:C`YC6?!&H:58O=SW-FZISA7(/Z@5U0Q
M*J2LD<L\,X*]]"#P=<V6DWIU34?,9(01"@7[SD?EP*JNI3CR1%0:A[TNAE:O
MJ$NJ:I/>3`AIWR!_='0#\JVA%0BDNAE.?,VV;UEKL.E>#WL[='%_>L=[$8VI
MT'/Y_K7/.DYU;MZ(V554Z=DM6<W:;'N8O,#&/<"P'7;[5U.Z1SI]&=1XOU>W
MU74[&QM)/*L;=50%AC:3C.1[#BN7#TW!.4MV=-::G-16R.D\2>';_6[2RMM-
M,-M8VRC:LK$%N,`X`/:N6E6A2DW+5G14I2J)*.B./U[PCJ6BVRSSO!(N<'RF
M)*\]Q@<5V4Z\:ETCEGAW!79@E1O]L^O;%=%V<VB$R-PX/([4[.VA+?1"#H">
MP[4=+(;785#\V0<>GYT/5#2MN:5WHM[]GN=3,)6U$K`.S`9.XC`'>L8U(\W(
MC>=.2O+H16^BW\VFR:BD.+6'AI&(4'`Z#U.<4_:13Y.I"I/EY^@EGHM_>V4U
MU#"?L\`)DE9L`<?YX%$JD8R47N$(-^\MD+INB7VHK-+:Q9CB&Z24D*JC'J:<
MZD(I18H0E)-I;&Q\/=)6^UL7,P_T>S7S7)Z$]OU_E6.)GR0MU9OAH\\KO9&9
MXIU-M7UNXN\YC)VQCT0=/\?QK2C3]G&QG5J<\VSI]+7_`(1GP+-?`;;[4/EB
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MK."7(R1T'2NYZG$C5\*:6=:UZWM`H";MTGLHZ_RK*M/V<&S:G!SDD;GC:6X\
M0>)/[,TF$S16*^6B1^O\7]!^%84$J5.\NIK6YISY8]#EUTJ[;4SIT4!EN5;:
M40AN1U'%=?M%;F>QS*$KV6XLNE7D.HBP:$M=C"F-2&()'3COR*E3C;FZ#Y'S
M<O4+S2+NRO5L9X2+DA?W0()YZ#`_E34U)<RV!P<7R]0O]*O--N8[>]B,4[@,
M(\@M@]..W>B$XR3<0J4Y1T>X[4-)O=+\I+V!H7E7<J,?F(]QVHA.,UHPE"4'
M[VAV.KX\+^`H=/3Y;W4OGDQU"]3^F!^-<<7[:MS]$=<[4J7+U9S'A;2GUG7;
M>T`^3<&E/H@Z_P`JZ:L_9P;.>E'GDD=!XJ=O$GBZWTBRP+>W(A4*.!_>/X`?
MI6-%>QI\[]3>J_:U%!;$'Q-U"-K^WTBT^6VL$"8'][']!_.GA(M1<WU(Q$O>
M48[(Y#'`_,UU-OJ<J6NAWOA!$\/^%K[Q!.`)95,5N#WY_J<?E7!5;JU%36W4
M[:*Y(.H]SAXTEO;L(N9)IGZ#N2?_`*]=K?*O(Y(J[.T\>20Z-HMAX<M=H95$
MMP5[G_\`7_*N.A><W59UUO<BJ:^9E_#S1_[2UR.6=0;:T'FR9Z<=!^8%:XBI
MR1:6[,Z$%*?D4/&&K-K.OW%TI_=*=D0]$'^)YJZ5-4X)&=:7/.YC<\=CZUT+
M0SLCO_"B#P]X0O==F`^T7`,=L#^0_7^5>?6_>5%36RW.VG^ZIN;.-FTN_-BV
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MJ_:U%36W4Z*5J=-S8>!8UTS2-1\2WHW,@9(B>K,>2?Q)`_.C$>])4D%!*$74
M9P\UQ-<3/)(QWR,7;!QR3DUV626AQ-O<DTNSEU74K>UB4EYGV<\XZT3DH1;[
M%0BV^5'5_$R[BA>RT&SQY%C'\P`_B(P/TS^=<N%6\WNSIQ,K6@NA'\-=*BGU
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M9*5[/8'"4=PNM.N[*&&6Z@DACER$+KMW<=1FB,E)M+H$HRCJ^IVM@B^&?`$U
MTR@7FJ_)'D9(4]/TR:Y)R]K62Z1.J'[JE?JSC=(T]]3U&WLH`"\KA0?09Y)_
M"NJI/EBVSEBN>22ZG6^.W6;4K'PSI:@16P5"HXW.W`_''/XURX?W8NK/J=5?
M62A$7XA7$6EV&GZ!9D#[*@DE8<'=V_,Y-&'4IR=3N*NU!*FCB_M$QR/-<J.H
M+FNY*QR7:9V?PYM(K*"]\0W@VPV:,(SCN1S_`)]ZXL3)R:I1W9UX9<J<WT.0
MO)Y+V^DN)%`>=RY4=B375&/*K+H<TVVSL]<@B\.>![;3`BB]U##S'&2`.?TX
M%<=.7M*W/T1TSM2I*/5G.>%-).KZ[;VFTF/=NEQV4=:Z:T_9Q<C"C'VDK&A\
M0-32^US[+:A4M;+]TBJ,#/\`%_0?A6>'I\D;O=FN(FG+39'-0RRQ']W(\61R
M4)&?RKHN<Z.Y\`1F&RO==U*222"U0JBR,2"W4\'OT_.N/$-MJG'J=>'T3G+8
MY6Z6]U*2XU%HGD1G+ROCY5SSU]NE=,>6-H['*U*;<BM;6%S<([P022)$"SL%
MR%'O^%6YJ+U$HNV@6ME<7?%M;O*5&6V#.!ZGTI<RCNR5%R^$2VL[B[E*6L,D
ML@XVHN:IR2W&HN6D=0AM9[B;R88GEDSC:HR<TN9)7>@*,KV1<T72)M0UJ#3]
MI1VDVL,?<`^]43DH0<NAI&'/)1-SXDWD,FJPV%HJK#I\8C&!SG'3\!BL<(GR
MMO=FF(DG/E70G^'VG01K=ZWJ"*;:S0E0XR-V/Z#^=3B)MVA'J5AXJSJ2Z$G@
MF!]6\0W6NZAQ#;DS'=T5OX1^`_E1B&J=-0CN]`HKGFYRZ'/:MK=S=:G<7-M/
M-!'+(S*D;E5QVX'<UT4Z2C%)HPJ3;DVC/DGNKME22::8GA0[EL'\36J2B9WO
MH=IXL6+0O"5CH@53<W!\Z8X&5YR?\/PKAH7JU'46R.RM^[IJ'5F!X-TG^U]>
MA@=/W*'?+VPH/3\>!^-=%>?LJ=S"A!5)V)?&U]#>Z],+1$6"V`@0*."%Z_J:
MG#P<8>]U#$24IZ;(VO"-O#I'A^]\0WL2LX!6V5QGG/;\<"LJS<YJE%^IM07)
M!U&<9)(\DDDLW+R,68D]\Y)_.NU)):'(VV]RQ;:A?Y2&"\NE'W559F`';@9J
M90CNT4I.UDSL/%\K:/X:L]*WF6^N5#7#N=S8]"?KQ^%<E!>TJ.:V6QU5VZ=-
M0ZO<XF>VGM]@GA>+>,J&&,CUKL370XI1:M<)K6>%(WEB>-9,E"5QN^E-23O8
M.1K41[6>*-)I(G2-CA7*X#'V]>E)/IU#E:2=@-O/'`)VA?RR=N_'!/UIIJ]B
MN635SH/&&OKJ=O#IUK`UM;VKMN0G.]LXSQ^/YUA0I*FVV[MG15K\UDEL0:KX
MA6[\.6.D6=N]ND)!D)(_>'U_/FE"ERU'-LB=6\%&UK!<^(E;PI!HEI;M"0VZ
M9MP._O\`Y^E$:5JCJ-BE57LU3BK")XB6V\)OHUI;M'-*Q,TV>''?],"G[&]7
MGDQQK)4^1(AAUZ:RT.33;",1?:"S3R_Q-VVCT'^-4Z2<U-]"(UG&G9&.!MX&
M?;/^?>M;]3+4V=>\03:TFGQO'Y<5K"$*CN>F1^&*QIT53NUW-JE5SLGT.BM_
M&.A?8X8+W3;JY6%0J(RH43`QP-WZUSRPU2_NR2.I5Z=M45-8U_PQ?Z;-;VNC
M2VL[#Y)%C0;3^!JJ=&K&2;D3.K2<;*)SWAW5'TC58[H>9L^[($QN9#C('O71
M5I\\+'/3FZ;N=:WBOPEG>^@2EFR2QC0D^Y.ZN3ZM7VY_S.KV]%NW*06OB_1(
MTEMY]/N7L3(7BMU5-HR!U^;GG-.5";U4M257II6:T(M3\3>&I+.1=/T$Q7/\
M#LJKL/J,$TX4:JDKRT"5:FE[L=3EK_4+C5;];G5)Y)&8@,0.57T`_I74HJ$>
M6)S2FYR]XZC3M:\&V5LD4FD75PZ]9)44LQ_.N:5*NW=22.F-6C%6L5=6\4V,
M4BOX6L#IKE"DDN`&93V`Y_.JA1E:U5W)G72^!6*_A7Q+#H4.H.]O)+>W"X27
M(PI]_P`<556A[5K70FG5]G?NQGA#Q!;Z#=W-U<V\D]Q(A6-P1P3R2<^O^-%:
MDZB23'3JJ#<F)X6UZ#3-=DU34H))Y'#%=A&5<]3S^-35IN4.2+)I5%"3DT)H
MVO16_B=M9U6"2X.YI`J$9#=NO8?TJZE-NGR0=AQJI5.:2"'7XY/%W]L:C!)-
M&)=XC!&0!G;U].*4J=J7)%BC4]_GDA-1UY-1\4MJEW$TD"N#'#QR%Y53]3U^
MM-4E"GR(7M.>ISLI:]K5UKM\;J[(!QM1%'"+Z"KITXTU9$U*DJCN6?"WB!]`
MENYEA#M-;LBGNK=0?I4UJ7M$E?J.E5=._F3>$=;M](O9KJ]\W?(N/,C4%AGK
MU[FE6I.44D72J*#NSHI/$G@R5F>71YI'<Y9F7)8^I.ZN=4:Z6DCH=6CV.1\1
MSZ7=:D9M$ADMX&49C<8VGOCFNNG&2C:;N<M5QYKPT-_0O$^E)HL=EXAM9[M8
M21$B@;`/ID<\FN:I1DY-TW8VIUHQA::O8GG\2>%X/*FTK2I+>ZBD5T=DXP",
M]_2A4*KTE*Z&ZM)+W59D\OB?PE<OYM]IES=3M]Z611EC_P!]<5*H5H_#))%^
MVI/=&%J_B:%3/#X<MVTZRG15EY^9NOUQUK:%%Z<[NS"I52O[/0H^'6T2*?S-
M;6>14^[#$O!^IJZJGM`BFX)WD=0^N^!Q&2FBRL0.!MQG_P`>KF]A7O\`&=$J
MM'^4Y35M;NM02*VE)2QMS^Z@7HH[?4\XS71"$8[;G-*HY>AH^+/$L&K6EA9:
M?;R06=J@^1\9+8QV]OYUG2HN#;ENS2K5YDE'H'B+Q'!?:#I^D:9!+!;P#]Z'
MQ\S?AGN2:J%%QG*<@J54X*,>@:EXDMY/"=IHEA!+$%;=<LV,.<YXP>A/\J(T
M6JCFWZ"E57LU&*$?Q';Q>"H]&L898YY7S<NP&&!ZXQ]`*:HMU>=[=`=5*'(A
M;'Q';:=X.N=*LXI4OKEOWDQQM*GTYST_G2=&]53;T'&K:FXK<@TWQ&VC:)/:
MZ;&%NKK/G3-_`H!P%JI45.2<GL3"HXQLNI@<@Y;D`G@5OH87MHC?\1>(VU32
M],L8HS#%9QX=!T9^F1^'\ZPI45"4F^ITU*G-%1.CL?$GAHZ-;Z?J2S2P1(,0
MK&P7(Y))'4YS[5SNC5YG*.YLJM.R316U2\\#W-A<165I+!<LA\N0(YVMVZGU
MIPCB(M7>@I2HVLD<OX>U)M(U>"\CXV'!(`)"D8./?&:Z:D>>#B<U.;C*YVLV
ML>!;B5I;FSFFE<Y>1U?+'WYKC5+$+1,ZG4H=4167B/PY"MW8JDL6ERR;Q$D;
M9?*@$$]<<54J56REU0HU:>JZ$=]JO@=;25K3396GVD(/F7GZDT0IXB]F]`E.
MBDVD<KJ^M7NMSQ-?RC$0"(`,*@]<?A75&E&FM#FE*4VFSHM'E\$6=FB7JSWD
MQZNT;*!]`.U<\UB&]-#I@Z,5J&H^(="TV2*?PK9-%=H3F60'`!&,8)Z\T1I5
M))JH]")U81UI[E'PEXAM-,U6[U'4DGGNG0F)P`1N/4G^5:5J3G%1CHA4JJ@V
MY#/"VN6EGXBDU;5DEDD;<R[`"`Y[_3%%6DY4U&)-.HHSYY#=(URU_P"$N.L:
MNDKH7,BJ@#8/\.?IBG.D_9\D0C47M.>0-KMO>^,AJ^JQR-:K+E449.T?='-/
MV3C2Y(/4/:IU.:0NKZY;ZOXN74+U)&L$D4+&.NP=OQYHA2=.ER+<<JJG/F>P
M_P`3:[;:[XBBN)1(MA$`J*!SMZGCWZ5-*DZ<.5;DU:BJ3OT*OBCQ#/KMQ%^[
M6VMK<;8(E_A''7WJJ5)4XONQ5:KJ.W8/!FLQZ'K(NYHO,3RV`(ZJ2.#_`)]:
M=>#G!Q0Z514Y798\.:O#;>(9-3U1OWCDN&VEMK'O@>G.*BI3<H\L0IU$I<TC
MH[C4_!%Y.\]XMS/<2'YI&5\D_A7.J=>*LK6.ASH3U9ROBK^Q6N4?P_O6`IAX
MV5A@^O/M7724[>_N<]7D^P:_AC7M+_L1]*\0&7[,CY1(T/SY.?F(]#652G/G
MYZ>YI2JQ2Y9EBZO/!<4!ETZ&47*$/'O5]I(.<'VJ(QKM^]L4Y4;>[N7;W6O"
M.J2>?J[SSS@8^5&54'H!4QI5H:0T1;J4I:RW,C4/$.G:3<,?"4+0F:/RY99`
M>,GC:#WXK2-*4U^]9DZD(.U,Q=%CTZ>\WZS=O#"IRVQ"SN<Y//:MIJ5O<1C!
M*_O,ZO?X!7&$GS]'KFY<3Y'3?#HY[5]>:XL3I.GH8-,63>B,/F89S\QKHA2L
M^9[F$JNG+'1%W6M>LV\*V.C:4'"K\TY88)/7^?\`*LH4G[1U)%RJIP48_,6X
MU^T@\%QZ/IV_[1,V;ABNWC/.#^0JO9-U?:/;H2ZJ5-00EGK]EIW@V;3[+>M_
M=O\`OF*XPI]#]/YT3HRE44GL@C6C&E:.[%T/7K31_#%]#;;QJ=R=H.W`5?K[
M`DTYTG.HI/8*=6,(-1W$\):Y8Z#I=_*0_P#:,T>R(;>,8XY^I_2E6IRJ-+H@
MI5(TXON5_#6NQ:&MU=B,SZA-\D>[A5SU8GUJZU%SM&^A-*JJ:;MJ84TSW$[S
M3/NDE)=F]R:Z.51T70P;;NS?GU]#X.MM%MXS'()"9_\`:7.1^?\`2N?V2]LZ
MG0W=7]UR(V_#>IZ%!X>_LZ]NS"DN3.J*VYR>Q..!BN>K"IS\R1M2J04.63%F
MM_`;1N$N)4?'!&[@_E2B\3IH-_5[6.-LYOL&I17$>V4P2AUR.&P>,_Y[UWR7
M/%HY$^65^QW=Y>>$=7D6ZU2[FDN&4`\,H7KP`!]:\]1KP]V"T.MSHR=Y/49I
MVI^'=)OIDTRZ\JUN(PKR,K%E.3D#COFG*%6<5S+4<)TXOW7HR&2+P$JEA+.[
M`$@#=D_I37UD5\/N<_J^O2W]E#IT*"*QMC^[0=6Y."??!KHA249<SW9SSJN4
M>5;(OZ!9^%UMQ)K6H,\SC_5QJP"Y]3CDU-5UKV@C2G&DE>;+=_/X2TV..YT?
MS9[R*17C0YVY![Y[5$(UY.T]$RINC#WHZLS]-UJ&^\51:IKSD(O.U5RHQ]T8
M],UK.FXTN2F8QK)SYJ@D^L6FJ>,!J&HLRV:RC"[<G8O08]_ZTE2=.ERQW*E-
M2J<TGH&OZQ;:UXJ2YGD9=.B8(I4<[!U./>BE3=.GRK<52JISUV)/%NMVNLZY
M;K$Q73H`J*0N,`]3C\/TI4:,J<'W'6J*<O)!XVUJWU1[2TTUB+&UC&WC&6Z=
M/8?UIX>E*E=RW8J]53:4-D>BOX9T5W9FT^(LQ))YZG\:\SV]3N>BZ-/L,_X1
M70QC_B6P_K_C1[>IW'[&'84^%M#_`.@=#Q]?\:/;U.Y/L*?8:WA70PN1IL((
M^O\`C3^L5>X>PIKH*?"NAC.--AZ8[_XT?6*G</84^PT^%M#V@_V=#GKW_P`:
M/K%3N/V-/L`\*:'@?\2V+]?\:/K%2^X>PI]@_P"$4T+_`*!L7YG_`!I_6*JZ
MB]A3["'PIH?_`$#HOS/^-+V]3N'L*?80^$]"P/\`B6Q#\3_C0L1474/84^PA
M\):">NFQ?F?\:/K%3N'L*?80^$M!Y']FQ?FW^-/ZQ5[A["GV$_X1+0>?^)='
M_P!]-_C1[>IW'[&GV$_X1'0<_P#(-C_[Z;_&CZQ5[B]A3["#PCH(QC3HQC_:
M;_&CZQ4[C]C3[#?^$/T`#']FQ_\`?3?XT?6*O<3HTWT#_A$-`S_R#H_^^V_Q
MH^L5.X>QI]@_X1#0/^@<G_?;?XT?6*BZ@J,%T$/@_0&ZZ;&?^!M_C1]8J=P]
MC#L'_"'Z!G/]G)_WVW^-'UBIW%["GV#_`(0_0.G]FI_WVW^-'UBIW#V--=`_
MX1#01_S#D_[[;_&E]8J=P]A3[#3X.T#I_9R#_@;_`.-/ZQ4[C]C#L+_PB&@`
M_P#(.0<_WV_QH]O4[A[&GV#_`(0_0./^)<G3^^_^-/ZQ5[A[&GV`^#]`Y_XE
MR?\`?;?XT?6*O</84UT#_A#]`X_XER?]]O\`XTO;U.X>QI]A/^$/T`#C3D_[
M[?\`QH^L5.X>PI]A#X/T#C_B7)P/[[_XT?6*G</8T^PG_"':!C_D')TQ_K'_
M`,:?UBIW%["GV%/@_0/^@<G_`'V_^-)8BHNH*A3VL)_PAV@8'_$N3_OX_P#C
M3>(J=P5"GV$/@WP_T_LY>F/]8_\`C1]8J=Q^QI]@_P"$.T`?\PY>O_/1_P#&
MCZQ5[B]A3["#P;X?&,:<O'_31_\`&CZQ5[A["GV$_P"$-\/_`/0.7_OX_P#C
M0\15[A[&GV%'@WP^",:<HQ_TT?\`QH^L5.X>QI]@/@WP_P#]`Y?^_C_XT?6*
MG<%0IKH(/!V@;B/[.7I_ST?_`!H]O4MN+V%.^PA\&^'\_P#(.7_OX_\`C5+$
M5+;D^QAM81O!^@A3C3U''_/1_P#&E]8J=QJC3TT$;P?H.?\`D'K_`-_'_P`:
M:KU.Y/L8+H1MX0T$*,:>HYQ_K'_QI>WJ)[E.E#L`\):&!Q8`<G_EH_\`C3]O
M4ON)TH]AG_")Z'U^P+P?^>C_`.-5[>IW)E2@GL)_PB>ALI!L%.#Q^\?_`!IQ
MK374;I0["?\`")Z'DC[`,8_YZ/\`XT.M.VX*C"[T$/A71!_RXKZ_ZQ_\:%6F
MK:B]C"^PB^%=%&?]!7J/XV_QIRJSON-TH6V&1^%M%V@?85X_Z:/[>]$JT[[A
M[*'8/^$8T8,N+(=/^>C?XT*K-K5D^S@K:#?^$7T8$8L@./[[>OUJO:S[E>RA
MKH-;PQHZL0+(#!/_`"T;_&J]K/N9^SCV$/AG1^1]B7@_WV_QJ/:SON-TH+H(
MWAG1\?\`'D..GSM_C356=MQJE"]K`?#6D`X%FO\`WVW^-/VL^Y'LX[6&R^&M
M'`.+,<?[;?XT>UGW*]G'709_PCND["?L@Z_WV]O>CVL[[@Z<;[#?^$>TK:?]
M$`P?[[?XT.I+N/V4--`70-+`'^BCJ/XV_P`:'4EW!TH=AIT#2QG%J..?OM[^
M]"J2ON-4H=AO]@Z8"H%J`"<??;_&CVDNX.E!:V$&@Z8-V+4#G^\WK]:'4E;<
M2I0[$;:'IHX%J!_P)O\`&FJDK[A[*%MA!HFG9`^S#_OMO\:'4EW$J<;["?V)
MIPP1;#U^\W^--5)6W)=.-MAC:-IX`Q;C@?WF_P`::G(7)'0<^CV'!^SCK_>;
M_&E[25A*$2-M)L<-^X'`/\1_QIQJ2NM1JG'300Z59`G]P.#Q\Q_QJ?:2MN+V
M<>Q'_9=EDGR!D?[1]_>M5-V&H1TT&KIEG\W[D<#/WCZ_6IYY#5.-M@?3+/G]
MR.O]X_XTO:2TU)Y(]A3IMH&XAZ'/WC_C3520<D;L1M,LP!^Y'`S]X_XT*I+N
M)0CV&KIMH1S"/S/O3=22ZA[./84:?:CI%CK_`!&GSR)C"(HTVTV+^Y'/N:%-
MZ%<D==`;3;0#B$#@?Q'_`!IQG(7)&ZT&OI]KDD18X;^(TN>20*$==`&G6OS9
MA'&>YH4Y"<(]AOV"U&X"+_QXU3G(KDC;8D.G6FPGR1D8'4U'/*VXG"-[`=.M
M`_$6/^!'U^M4YR$H*P)I]KOC'E<$#^(T<S0."M8C_L^US_JO7N?6CGD)05@^
MPVW/[O\`B/<^E-2>A*@A5L;;#'ROXL=3Z4.3*E3CV`6%KE/W0[=S3<G<EQ5A
>GV*W48$>!GU/O5*3N$H1'FQM@.(OU-1SR+44?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>bms-logo.jpg
<TEXT>
begin 644 bms-logo.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``4%!0@%"`P'!PP,"0D)#`T,#`P,#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T!!0@("@<*#`<'#`T,
M"@P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#?_$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`"<!*0,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/LN@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`
MH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`/'?&>F3>-9%AB8
MBVC>>*W0$;+B>*)S*[Y^7:'7[/$Q'[MUEE&X%*]>A-89-M>\U%R?6,6U9+Y/
MF?=67<\BO!XEI)^ZG)1724DG=ORNN5=G=]BOHABFLX/*-M%&_F17/VJV1Y;-
MX(C))M=RI961=RBZ\V2+>#*\FTQ!U+J4K\S:LX\LFE-2=EHNM]'RV3MHE>Y-
M.SC&W*EJI<T4W!Q5WJ^EM5S7:OJW:QAZ%H<_VQ-?TW?$\T\HMHG8`W,<$+[A
M-P%7SP&10$5+>0NT8,8CK>I47*Z%2S2BN9K[+DUMUTW>K<E:^MS&G3?,J].Z
M;D^5/[2BGOT][9:)1=[:6/?+&]BU"".Z@),<JAER,$9ZAAU5E.593RK`@\BO
M"E%P;B]U_7W'NQDII2CL_P"OO[F'XN\3Q>$-.?5)XI;B.-E4K$%R"YVJSEF`
M5-V%+<G<R@*<UO0HNO-4HM)N[U\NWGU,*]98>#J23:5EIY]_*^GS.6_X6++8
MM9MK&G2V%MJ;(D$XFBF57DP4695"M'D$,>I`SQE6`Z?JJESJC44I0NVK..BW
MMW.7ZTX<GMJ;A&=DG=/5[72M;^O,]/KS3TS"T/Q%:^(/M'V3S/\`0[B2UDWH
M4_>1XW;<]5YX/!]0*WJ4I4>7FM[T5)6=]&84ZL:O-R7]V3B[JVJ+VH:I:Z4J
M/>2I`LTJ0Q[SC?+(<(BCJ6;!.!T`+'"@D9QA*=U!-V3;MT2W9I*<:=G-I7:2
MOU;V2+]06<KK7BJ/1-0L=,>&5VU.1HTE&T1IM&6W$G<6&0=H7!!SNR,5U4Z+
MJ0G4324%=K6[O^'XG+4K*E.%)I^^[)Z65OQ_#YF]J-S)96TEQ#$;AXU+")65
M"^.P9R%''.2?UXK"*4I*+=DWOJ[?):F\FXQ<DKM+;17^_0YKP5XTM/&]FUY:
M*T31.8Y(G(+H<94\<%64Y4CC(8=5-=&(P\L-+DEK=736S_X8YL/B(XF//#2S
MLT]U_P`.4;3Q_!J/B"7PW9023O:J6GG#QK''MVA_E8AFV2.L;!?FW;L`A2:T
M>&<**Q$Y)*7PQL[N][>ETF_0B.)4ZSP\(MN/Q2NK+:_W-I>IW]<!WA0`4`%`
M''^*O%\?AE[6U2"2\O-1D:.V@C*IN9-NXO(Y"HHWKDG/7.,!B.NC0=92DY*,
M(*\F[NU[[);[,Y*U=4.6*BY3F[1BK+:U[M[;H9H7BJYU+4)=*O[&73KB&%9U
MWR)*DB%RA,;QC:0IV\YSDD%5(Y=2C&$%5IS4XMVT333M?5,5.M*<W2G!PDE?
M5IIJ]M&M#LZXSL"@#E[SQ9:6E]+I02>:[M[4W92./(:,-MVH[,B%\D<%E7MN
MW`@=,:,I056\5%RY;M[/S2N[?CY'-*M&,W2M)R4>:R73R;LK_AYD_A3Q#'XK
MTR'5H8VACN/,VHY!8".62+DCCG9NP.F<9.,TJU)T*CI-W:MJO-)_J.C55>FJ
MJ5D[Z/R;7Z%30/%D>O7]_IR02V[Z6T2.9=@+F82$%0C-A<1Y!)R0PX!R*JI1
M=*$*G,FIIM6OI:W>W<FE656<Z:BTZ;2=[:WOVOV_$ZRN4ZCS@_$!]1NIK3P_
M83ZL+-MD\ZR0P0!QU2.25@)7!X(``[@E"&/H?5E"*E7FJ?,KQ5G*5N[2V7];
MGG?67.3AAZ;J<KLVFHQOV3>[_K8Z/POXA_X2.V>=X)+*:">2"6"7[\;IM(!X
M`^9'1QCC#<$CD\]:E[&2BI*2:4E);-/_`(*:.FC5]M%R<7%IN+B]TU_P&F=)
M7.=`4`%`!0`4`%`!0`4`%`',>,[ZYTS1;NZLLB>*$E6`)*`D!Y`!U,2%I!_N
M\\5TT(QG5A&>S?W]E\WI\SFQ$I0I3E#=+[N[^2U^1YII0O;JU27^RVNS`@C2
M8:I!$;;8H!2%4"FU9`-K@XG(^6X>0YSZ,^6,FO:\MW=KV4GS7ZMN_-?I]G^5
M(\V'-**?LN:RLG[6*Y;=$E;EMU^U_,V>7:SJ4YGNI7F-N[D,L:[9A<$*V\F6
M`)#)L!:1V@5$<LZR!C+FO3IP244E=+K\/+M;25VK[*[;6EK6/,J3=Y-NSWM\
M7-O?6-D[;OE23NT[W/4M,%[<VJ3#2VNO(79'<+JD$9MA&,%(%C"+:^6!L=0!
M(0NVX:0@UYD^6,FO:\M]7'V4GS7ZRO?FONGMUC8].',XI^RYK:*7M8KEMTC:
MW+;9K?I*YN_#C5+V]FOX9U_<)*DJ/N1QYDH+2`2PJD$WF$"9F@1$#NSD9E!K
M#%0C%0<7K9IK5:+;1WDK;:MNRMT-\+.4G-27NIIIZ/5[ZJT7??W4E=M]2?XQ
M?\BG??\`;M_Z5V]+`_[Q#_M[_P!(D5CO]WG_`-N_^EQ//_&\5]I=MI6L:HZ7
M^CVLENWV.-#!(C-'F-W?=)YVP`CK$&)`*!68CNP[C.56C23A5DI>\WS)ZZI+
M2U_GZG!B%.G&E6JM3I1<7R)<K3MHV];V^7IJ=1I&J>(]>U[4+*&_MX;339;4
MX%F"9(IP\FQ=TFY24!#LSL=P4H(P6%<TX4:5*G-PDY34OM[-65]K;[*WK<Z8
M3KU:U2$9Q48./V-U*[MO=:;N_:UC$E\8^)?[.U*:)A<2:=K#VDTEO;H7ALXA
MB22"!RX9MP#?O7EV!CN)0%TW5"ASTT]%.DI)2D[.;V3DK?@E?IKH\77K\E1K
M5PJN+<8JZ@MW&+OU[MVOKIJL3Q)?W6OZ;IUY'JBWUN^NVR0,+>*.6(F([?/C
M"*%EA<2':,I*L@?[NQ1M2C&E.I!TN22HR;7,VGK]EW>C5M=TU;N8U92JPIS5
M7FC[:*C[J36GVE9:IWTV:=^QW6D:CK_BN[U""UOUL(=(F-FK"VAD>YGBRLDL
MP<$(C,N0D00X;`8%<MPSA1H1IRE#F=1<]N9I1B]DK;OS=_Q.V$JU>52,)\BI
MOD7NIN4ENW?9>2MOY')1>)I_%5SX<NKQ%CN8=1N[>;9]QGB2++*#G`8,,C)P
M<XXQ76Z*H1Q$8/W73C)7WLV]#E59UY8>4U:2J3B[;726J/5H_'FBZM(^G6D[
MO<LDP"&WN4!,<;LWSO"L?"JQ^]@XP,DC/EO#5::5244HW6O-%[M):)WZ]CU%
MB:4VZ<)/FL].62V3;U:2Z=SPC1DU#P3;:;KFBQ&==<M!9RPC[OVWYA;2^G)`
M.,<A9LD&3(]NIR8B52C6=O92YT_[GVE_7==CPZ:GAHTZU%7]K'D:_OZ\K_KL
M^YT6B:#<Z+XJNM.TR54O(M"#"9U#B2X:>W>1Y`V,B:4L6/50W'0"N>I4C4P\
M:E1>XZVRTM&TDDO1'13IRI8B5.D[35'=ZWES1;;]6;=EX\O]0TJRD281ZAYM
MW]O0PH?+BLD:6?Y?X65?)2/KEIANY!`QEAH0J37+>%H<CN]7-I1U^]OTT-HX
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M*RJP)P5;DP^(>';NE*$E:47U7]-^1V8C#K$)6;C.+O&2Z/\`I+S/-#\3]5\+
M6E]I>O1(^L:="CP2C_57*221Q*[;=O*F02';L#J&4B.13N]'ZI3K2A4H-JE-
MM-=8M)MI?=;K;?5'F_6ZE",Z5=+VL$G%]))M*[^^_2^VC-2]O?$FDWNBPW.H
MB;^U9#YT?V:%$B=8U?8ICV/)%N?#`NKL$&'7=QG&-"<:SC3M[-:/F;;3=KZW
M2>G:VNS-92KTY48RJ7]H]5RI)-*]M+-K776[MNC.D\:Z\/"-]K(N(A>65^\!
M?R%QY7FPQ`1KG:I#2;@TBRY4%3DD,+6'H_6(4>5\LH)VYNMF]>O3I;]#-XBM
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M;M6]Y7M;=G1%3=7$RI2Y6N1[)W]UV3OLCO\`PSXANO%'A==5VA+N:WG&%!"^
M=$98@R]3AF0,`"<9VY)%<-6E&A7]E]E2C]SL]?DSOHU95J"J[2<9;=U=:>K1
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M?$4!8J;2,+;!8H93*NTJTDOER;BK,L7F`@)L(`OV>'M6_=M>QE_.[RU:MV2N
MO6W6Y'M,0G17M%^^C_(K1T3OW;L_2_2Q5U'QOXBT73]74W,-S<:/>PPBX>W1
M6>*?<H`CC*Q*R-M(+*X(W`@G!%0P]&I.E[KC&I!OE4G9./F];/Y$3Q%:E"JN
M9.5.<5S.*3:EY+2Z]&=5-KFL^%-:M=*U*]COK?4K>=EGE@BA-M-!&SEF$)C5
MH.`6#$-M)^<;<MRJG2KTI5:<'"4)1]U2;YE)VMK>TOZMJ=3J5:%6-*I-2C.,
MO><5'E<5>^EO=_JYD:1XSU)]9TZ".^?4;'4VNHV:6P6UBW01AM]JP"R2)O;!
MWNW0C.3E=IT(*E4DX*$Z?*[*;D_>>TELG;LD90KS]K3BIN<)\RNX**]U;QZM
M7[MF<GB;Q3=:7JVKB_BA71[R6)$2TBQ-Y10.C;RY2/:P*8+2[G8-*0J@:>RP
M\:E*ER-^T@FVYO2][/2UWWV6FQG[7$2IU:O.E[.;22@M;6NM;V7;=Z[G06?B
M[4;+5436+H1:?J&F-?6I6*("-Q$)9HBQ0LQ@7>Z;B0RA`^YB:YY4(2IOV,;S
MA4Y):O57LG:_VG9/SO8WC7G&HE6E:$Z?/&R6CM=K;[*NUY6N>@>#)-1N-*AN
M=6D\VYN1YV"B1^7'(`8XR(U4%@F"Y(SO9AT``X*ZA&HXTE:,=-V[M;O7SV\C
MOP[FZ:E5=Y/79*R>RT\M_,ZFN8ZA&0."K`,K`@@C((/!!!Z@]Q1MJ@WT9XWK
M+6'AZ=(-2C$BVPD:,L<?;+41M]GAE_AF-O,%@Q,'"#R9GV^;FO7I\]5-TW:]
MK_W)77,UU7,KRTM?5+8\>IR46HU%\-[?WXV?*GT?*_=UO;1O<S;/3K2[3SM2
M+27%T\DM]+%%(RV0:)EMT=@C+$\+%',;DM;_`"B3]S$K5I*4HNU/2,4E!-I.
M>JYFE=735U=?%TU=C.,(R5ZFLI-N;2;4-'RINVC3L[/X>NBN0V.I6@,-G?QQ
MW-Y:R&#:K`KJ$?E,;'=R5G7=Y91I?,V(4G<KYC8J4):S@W&#7-_U[=_?\XZ7
MO:UW>*V%&<?=A-)SB^7_`*^*WN>4M;6O>RM)[GM.CZ<=-MQ&Y#S.3)/(!@/,
M_+L!V4<)&O\`!$J(.%%>/.7.[K1+1+LEM\^K[MMGL4X\D;/=ZM]V]_ET79)+
MH9?C'PNGC#3FTN6:6V1W1V:+:=VP[E5PP.Y-VU\`J=R*=V`0=*%9X>:J**;2
M:UZ7ZJW6VGS9E7HK$0=)R<4VGIY='Y7UZ:I'*S_#FXU:.VM-<U%[ZQL61DMD
MMX[<2&-=J><X>1GP,@X"9#'&#\U=2Q2IN4J--0G*]Y.3E:^KY596_$YGA744
M85JCE"-K145&]M%S.[O^!T&A^$VT74K[5!<M,^I[#(AB154Q`K$5*G.%5F4@
M_>R"3D5SU*WM(0I<ME"]G=]=[^K-Z=#V4YU>:[G:ZLE:VUO1,P+3X>7FFO)-
M8ZI+#-/>O?2-Y"%7DE1UD1HPZHT;%E;:P.W;\FUCN'0\5&:49TDTH*"]YZ)-
M-.]KW_.^IA'"R@VX56FYN;]U6;:=U:]K/\+:%5OA4ALVB6\9;Q]1CU-K@0((
M_/C#@*MNK!5C^=CCS"=W))'%5]<?-?D]Q4W3Y>9WY7;[5M].Q/U)<ME/WG45
M3FY5;F5_LWVU[FA;^`KS3)I[G2]3DM9+\!KPM;12K)/@[IXES&('<LS$#>N3
MT("A<WB8S48U*::A\%I-6C_*]^9+Y,M8:4'*5*HXN?Q^ZG>7626G*W\T0P_"
M^"R&GK97,D(TJ1YT+1I(TL\I'FR2L<9W`*H4`;0.IJGBW+VG/%/G23U:2BMD
MOS$L&H>S4)->S;:T3;D]V_4]&O[>2[MY((I/(>12HD"ARN>"0K<'C/7BO/BU
M%IM72Z;'H23DG%.S?7>WR,GPOH)\-:?'IAF-REOD1LZ*C*G4*=O!P<X;J0<'
MIDZUJGMINI;E;W2;>O<RHT_8P5*]TMFTEIVT,6#P9);:_)XD^VN9)8S"T1BB
M"?9]RL(MWWAM**?,^\2#DX)%;.NG16'Y%9.Z=W?F[_.[TV,50<:SQ'.[M6M9
M6Y>WX+7<Y_P'I-CJ][JOB."+%MJDK00!NDD*`+<2@8&%NIP6(//R#.#6^(G.
MG&EAV_>II2?DW\*_[=7YF&&A"I*KB(KW9MQ7FE\3])2_(TM)\`W6AQ'3['4Y
MX=-WEEA6*+[0BLVXQI=')522>?*WC)VL"<UG/$QJ/VDZ<74MO=\K\W'O\[>1
MI##2I+V<*LE3OM9<R\E+M\K^98T_P-)IZ:D%O9=^L>8[NL:QM#-(I`EC*,&&
MW.0NX9P.14RQ"E[/W%:G9)7O=+H[KKW*CAW!5+3=ZEVW:UF^JL_P'Z9X)F@U
M:/6]2O#?7-M`;>$B".#"MD%I2C,9GP6`/R*-Q(3/-*>(3INC3AR1;YG[SEKY
M7M9?>_,(8=JHJU2?-**Y5[JCIYVW?W+R+'B'PG<:KJ%OJNGWSZ;<VT4D+%(E
ME65'96"NKL%*J0Q*D-DL&4HR`F:5:-.$J4X*<6T]6U9JZNK=?ZUN55H2G.-6
MG-PE%-:).Z=G9I]/ZTL81^%L&H_;)]<NI=1O-0A6!IO+C@$*(R.GDQ)N"D21
MHV2S`@8(.YR^_P!<<.2-"*A"#YK7;NW=.[=NC?\`5K8?4U/G=:3G*:Y;V4;)
M6:LEMJE_5[\=XACD\/:SX?M-3U%+PP3L5WQ1P-%#M6-&DVNQ8R$;=[$!FC.T
M`[JZZ356E7E2IN-X]&Y7>[2T5K;V\_0Y*J=&K0A4J*5I:72C96LF]=;[7\O4
MZ6Z^$YN+6YTM=1GCTZ[N6NC;B&$LLC,K8,I^=D!487"\A22<'=SK&<LHU/9I
MU(QY>:[V]-DSI>"O&5)5&J<I<W+9;O7?>WW&Y_P@DW]HMJOV^19Y+'[`VR&(
M?NL`[EW;P'\P"3)!'\.-M8?6%R*ER*RGSZM[_AI;0V^K/G]KSN[AR:);?CK?
M4Q;+X5M'9V^CWM^]UI-I,9EM1`D1<[VDVRS!V9X][L2H5<Y//"[=I8SWI5H4
MU&K)6YN9NVB5TK*SLC&.#M&-&=1RI1=U'E2OJW9N[NKLM2?#J\2[O[FUU66%
M-8P+I6MH7D**&55CD!01E4=D#",G:<D%@&$K%1Y:<94DW3^'WFE?1ZK6^JOO
M^!3PLE*I*-5I5/B]U-VUV>EM&UM^)WVAZ-;>'K&'3;,%8+9=JY.6.269F/&6
M=BS-@`9)P`.*X:E256;J3W;_`*^Y:'?3IQHP5.&T5I_7F]3B5^'LVDWDUWX=
MU"72TO&\R:W,,=Q`7)Y:-)"OED\]"<<`?(`E=GUE3BH8BFIN*LI7<96[-K?^
MNNIQ?573DYX>HZ:D[N-E*-^Z3V_KIH+-\.%9H+Z.^N1J]K*\HOI-LK,9$"/&
MT)VQB`H-JQ)L"`D`_,V18JW-!PC[*22Y%I:SNG??FONW>XWA?AFIR]K%M\[U
MW5FK;<MMDK6(Y?AP;W[9<7U[)/?ZE`+62X$,:+';\;HH802$WX&YB[MD9&"6
M+-8KEY(P@E"#YE&[=Y=V^MNUD)X7FYY3FW.:Y7*R24>R72_>[_,L?\("^_2I
M!>N#H,9B@_<Q_.I58SYG/4Q(B<8P5+]6XGZRK55R+]Z[O5Z==/FV_P`"OJVM
M)\[_`'2M'1:]-?DDOQ/./B;X;7PWH^I7<EWYLFL7%NQB9$3,D<H8>7@[B%CW
MY7GCYB<CGT,)5]K4IP4+*G&6J;>C77U=CSL72]C3J3<[NI*+LTEJG?3T5SO9
M?`L7BB;^U-3OCJ$4EI-!:>5&D*1Q72,K2AE9Q+(8WPKX5.AV'`KA6(=!>RI0
MY&I)RNVVW%[=+*ZVW\SN>&59^UJ3YTXM1LDDE);Z7N[/?1>17L?AI<VLFGRR
MZG)*=%WK:#[-$BK&X"LKC<Q<E`J%BPX4$`-DFI8N+51*FE[2W-[SW7;MKK8F
M.$E%TVZC?L[\ONI63Z/OII<LP_#AH=-OM*%](8M5G:XF;R8]RO)CS=G/`?:G
M7.W;\OWC4O%7G"KR*].*BM7LMK^EWZEK"6A.ESNU23D]%N][>NGH8GBC0[74
MI]%\)2G[5/;,+B67:$V6,",C*X!/_'QM2$8X9D+'&`#M1J2@JV*7NQ?NI;WG
M)WT_PZOT=C"M3C-T<(_><?>;VM"*MK_BT7JKGM0``P.`*\<]D*`"@##USPWI
MWB1$BU*$3K$6*'<\;+N&UMKQLC@,O#*&PPX8&MJ=6=%MTW:^^B:TVT::TZ&%
M2E"LDJBO;;5IJ^^J:>O4?;Z!9V<:P6XFBBC&U42YN551Z*HE``]@*'4E)WE9
MM[MQC?\`(:I1BN6-TELE*22_$H67@S1].O/[2M[<+=Y)\PR2N064JS*'=E5F
M5B&90"V<L2:N5>I./LY2]WM9+SZ)?(B.'IPE[2,;2[W;\NK^_N=17,=(4`%`
M!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4
,`%`!0`4`%`!0!__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
